K2M leads the pack with 3D printing for spine, analysts say

K2M (Nasdaq: KTWO) continues to lead the 3D printed spine device market with its new 3D printed Mojave expandable cage and its Cascadia family of 3D printed implants, according to a new equity research report out of Barclays.

Leesburg, Va.–based K2M presently has a 3D printed portfolio with 10 approved products making up about 12% of its revenues.

“We continue to believe KTWO is the leader in 3D implant innovation and portfolio breadth. Benefits of 3D printing include intricate design geometries that can’t be replicated with subtractive (traditional) manufacturing, reduced density of titanium leading to enhanced and optimal imaging,” Matthew Taylor, Young Li and Ian Mahmud said in their Wednesday report, published after Barclays hosted K2M CEO Eric Major at its Miami Healthcare Conference.

Barclays analysts think K2M is well-positioned to deliver on 2018 guidance since the company is guiding based on approved products and sales reps who are already onboard. The company saw a shortfall in the third quarter of 2017 because it bet on product wins and salesforce additions, according to Barclays.

K2M’s revenue in 2017 grew 9% year-0ver-year, to $258.0 million. The company, founded in 2004, saw losses of $37.1 million last year, a narrowing from $41.7 million in losses the previous year.

The company expects revenue to grow another 9–10% this year — to $280 million to $284 million — with losses continuing to narrow, to $30 million to $34 million.

From the Hospital Bed to the Finish Line Heidi Dohse was diagnosed with a rare arrhythmia in 1982 and has been 100% pacemaker dependent for over 30 years. With the help of wearable devices, she has been able to pursue her dream to become a competitive cyclist. You can hear her story and more when you register for DeviceTalks Boston, October 8-10. REGISTER NOW Use code FINISHLINE to save an additional 10%.